Most commonly, the first manifestation of MEN2 is medullary thyroid carcinoma, which strongly correlates with the underlying RET pathogenic variant (which is not the case in MEN1 for MEN1) [146,147,148]. Here, MEN1 is linked to medullary thyroid gland carcinoma.